Lunai Bioworks starts new oncology collaboration with clinical-stage partner

Median Technologies secures FDA clearance for AI lung cancer screening software

Sanofi's rilzabrutinib receives FDA breakthrough and Japan orphan designations for rare anaemia

Ascentage Pharma receives China IND clearance for BTK degrader APG‑3288

Partner Therapeutics' zenocutuzumab-zbco granted US FDA Orphan Drug Designation for treatment of cholangiocarcinoma

FDA issues EUA for Boehringer Ingelheim's IVOMEC (ivermectin) 1% Injection

Cumberland Pharmaceuticals secures FDA Fast Track status for DMD heart‑disease therapy ifetroban

Hologic receives FDA approval for Aptima HPV assay as primary screening option

AbbVie submits FDA and EMA applications for new upadacitinib indication in NSV

Relay Therapeutics wins FDA breakthrough status for zovegalisib in breast cancer treatment

DATROWAY receives US priority review for first-line metastatic triple negative breast cancer

Lupin launches Dasatinib tablets in US market

Natera submits Signatera CDx PMA to FDA for bladder cancer use

Pharming receives FDA complete response letter for paediatric Joenja application

Trace Biosciences' IND application for nerve-specific imaging agent approved by FDA